Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

3,4-dihydroxyphenylacetic acid has been researched along with 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hallberg, A; Nilsson, K; Pileblad, E; Tunek, A1
Bédard, PJ; Di Paolo, T; Rouillard, C1
Carr, LA; Rowell, PP1
Bruno, JP; Hadjiconstantinou, M; Neff, NH; Weihmuller, FB1
Block, F; Clement, HW; Grote, C; Sontag, KH; Wesemann, W1
Gerlach, M; Przuntek, H; Riederer, P; Russ, H; Stasch, JP; Traber, J; Winker, J; Witzmann, K1
De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M; Migheli, R1
Berrian, J; DiStefano, L; Schneider, JS; Smith, MG1
Hasegawa, E; Murai, Y; Oishi, T1

Other Studies

9 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine

ArticleYear
Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
    Pharmacology & toxicology, 1991, Volume: 69, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; In Vitro Techniques; Isomerism; Limbic System; Magnetic Resonance Spectroscopy; Male; Mice; Mitochondria, Liver; Monoamine Oxidase; MPTP Poisoning; Rats; Rats, Inbred Strains

1991
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
    European journal of pharmacology, 1990, Aug-28, Volume: 185, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone

1990
Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
    Neuropharmacology, 1990, Volume: 29, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Liver; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase; MPTP Poisoning; Nervous System Diseases; Smoking

1990
Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse.
    European journal of pharmacology, 1990, May-16, Volume: 180, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; In Vitro Techniques; Kinetics; Male; Mice; Receptors, Dopamine; Spiperone; Substantia Nigra; Up-Regulation

1990
Functional studies on monoaminergic transmitter release in parkinsonism.
    Progress in neuro-psychopharmacology & biological psychiatry, 1993, Volume: 17, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; 5-Hydroxytryptophan; Animals; Apomorphine; Biogenic Monoamines; Dopamine; Dopamine Agents; Dopamine Antagonists; Hydroxyindoleacetic Acid; Levodopa; Male; Monoamine Oxidase Inhibitors; Parkinson Disease, Secondary; Rats; Rats, Wistar; Stereotyped Behavior; Tryptophan

1993
Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Caudate Nucleus; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Mice; Mice, Inbred C57BL; Nimodipine; Serotonin

1993
Correlation between 1-methyl-4-phenylpyridinium ion (MPP+) levels, ascorbic acid oxidation and glutathione levels in the striatal synaptosomes of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated rat.
    Neuroscience letters, 1993, Oct-29, Volume: 161, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Behavior, Animal; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Glutathione; Male; MPTP Poisoning; Nerve Endings; Oxidation-Reduction; Pyridinium Compounds; Rats; Rats, Wistar; Synaptosomes; Uric Acid

1993
GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse.
    Brain research, 1994, Feb-14, Volume: 636, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dopamine Agents; Female; G(M1) Ganglioside; Heterozygote; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Neostriatum; Neural Pathways; Neurons; Substantia Nigra; Tyrosine 3-Monooxygenase

1994
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Cysteamine; Dimercaprol; Dopamine; Dopamine Agents; Glutathione; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Nerve Degeneration; Nervous System Diseases; Pyridinium Compounds; Sulfhydryl Compounds

1993